cervical small cell carcinoma
Showing 1 - 25 of >10,000
Patients With Neuroendocrine Cancer of the Cervix
Recruiting
- Cervical Large Cell Neuroendocrine Carcinoma
- +21 more
- Follow-Up
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)
Withdrawn
- Cervical Cancer
- +2 more
- ITIL-168
- (no location specified)
Dec 16, 2022
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
Advanced Malignant Solid Tumor, Anal Carcinoma, Biliary Tract Carcinoma Trial in Jacksonville (Clinical Encounter, Home Health
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +18 more
- Clinical Encounter
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jul 24, 2023
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer Trial run by the (NEO-201 in combination
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- NEO-201 in combination with pembrolizumab
-
Bethesda, MarylandNational Cancer Institute
Apr 1, 2022
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
Cervical Cancer, Colorectal Cancer, Esophageal Cancer Trial (89Zr-DFO-girentuximab)
Not yet recruiting
- Cervical Cancer
- +13 more
- (no location specified)
Sep 28, 2022
Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in
Not yet recruiting
- Head and Neck Cancer
- +8 more
- Tumor and HLA Profiling
- (no location specified)
Mar 31, 2023
Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +
Recruiting
- Melanoma
- +14 more
- LITT + Pembrolizumab
-
Gainesville, Florida
- +1 more
Aug 22, 2022
Head Neck Cancer, Cervical Cancer, Endometrial Cancer Trial (ILB-2109, Toripalimab)
Not yet recruiting
- Head and Neck Cancer
- +9 more
- (no location specified)
Jul 12, 2023
Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)
Recruiting
- Microsatellite High Cancers
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 8, 2022
NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)
Completed
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Augusta, GeorgiaAugusta University Georgia Cancer Center
Jun 10, 2022
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Melanoma, Non Small Cell Lung Cancer, Cervical Carcinoma Trial in Tianjin (Autologous tumor infiltrating lymphocytes (TILs))
Recruiting
- Melanoma
- +2 more
- Autologous tumor infiltrating lymphocytes (TILs)
-
Tianjin, ChinaTianjin Beichen Hospital
Aug 1, 2022
A Multicenter Cancer Biospecimen Collection Study
Recruiting
- Cancer of Head and Neck
- +10 more
- OncoPrismâ„¢ assay
-
San Francisco, CaliforniaCurebase
Mar 8, 2022
Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11
Recruiting
- Advanced Solid Tumor
- +24 more
- MDNA11 Monotherapy
- MDNA11 in combination with checkpoint inhibitor
-
Santa Monica, California
- +7 more
Nov 1, 2022
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022